72 completed, 19 unknown, 5 recruiting, 5 withdrawn. 29 Not applicable, 25 Phase 2, 15 Phase 3, 10 Phase 1, 10 Phase 4.
Follow Allergic Asthma: new trials by email Literature Review of Allergic Asthma trials Research Report on Allergic Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome Modified Shenling Baizhu Powder, Placebo, Budesonide and Formoterol Fumarate Powder for Inhalation - Allergic Asthma | Not applicable | Not yet recruiting | Henan University of Traditional Chinese Medicine | 400 | 2026-01-15 | 2026-01-20 |
| ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar Omalizumab - Chronic Spontaneous Urticaria (CSU), Allergic Asthma | Recruiting | Celltrion HealthCare France | 225 | 2025-10-02 | 2026-02-23 | |
| Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study Observational - Allergic Asthma, Thunderstorm Asthma | Not applicable | Recruiting | University of Melbourne | 530 | 2025-08-27 | 2026-05-06 |
| Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma ALUTARD SQ® Felis domesticus - Allergic Rhinitis, Allergic Asthma | Phase 1 / Phase 2 | Recruiting | University of Zurich | 36 | 2025-08-20 | 2026-03-16 |
| A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies Environmental Probiotic Spray Intervention, Purified water spray (containing no active ingredients) as the placebo control - Cat Allergy (Disorder), Allergic Rhinitis | Not applicable | Enrolling by invitation | Second Affiliated Hospital, Zhejiang University, School of Medicine | 100 | 2025-06-30 | 2025-08-11 |
| Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients LP-003 Injection, Omalizumab, Placebo - Allergic Asthma | Phase 2 | Recruiting | Longbio Pharma | 200 | 2025-01-25 | 2026-01-15 |
| A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma Briquilimab, Placebo Comparator - Allergic Asthma | Phase 1 | Terminated | Jasper Therapeutics, Inc. | 17 | 2024-11-26 | 2025-09-16 |
| Trial of JYB1904 in Patients With Allergic Asthma JYB1904, Omalizumab - Allergic Asthma | Phase 2 | Completed | Jemincare | 69 | 2024-06-19 | 2026-06-15 |
| A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients OM-85-IN, Placebo - Allergic Asthma | Phase 1 | Completed | OM Pharma SA | 41 | 2024-06-14 | 2025-03-03 |
| Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma Allergen-specific immunotherapy(AIT), omalizumab - Allergic Asthma | Unknown | Qianfoshan Hospital | 60 | 2024-06-01 | 2025-01-13 | |
| Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis Standardised allergen extract from house dust mites - Allergic Rhinitis Due to House Dust Mite, Allergic Asthma | Unknown | ALK-Abelló A/S | 100 | 2023-11-21 | 2024-03-20 | |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract 3,000 MM09, 9,000 MM09, Placebo sublingual - Allergic Rhinitis, Allergic Asthma | Phase 2 / Phase 3 | Not yet recruiting | Inmunotek S.L. | 90 | 2023-11-01 | 2023-10-23 |
| The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma respiratory exercises, relaxation exercises - Allergic Asthma | Not applicable | Unknown | Istanbul University - Cerrahpasa | 100 | 2023-02-03 | 2023-03-01 |
| A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers Genolair, solution for subcutaneous administration, 150 mg, Genolair, lyophilisate for the preparation of solution for subcutaneous administration, Xolair®, solution for subcutaneous administration, 150 mg - Allergic Asthma | Phase 1 | Completed | AO GENERIUM | 180 | 2023-01-15 | 2024-07-10 |
| Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen Immunotherapy Allergen Immunotherapy Extract - Allergic Asthma | Not applicable | Completed | Mansoura University Hospital | 100 | 2023-01-01 | 2026-08-18 |
| Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis MM09 allergoid-mannan conjugates subcutaneous (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (9.000 UTm/mL) - House Dust Mite Allergy, Perennial Allergic Rhinitis | Phase 3 | Unknown | Inmunotek S.L. | 400 | 2022-12-01 | 2022-11-18 |
| Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract Polvac Grass+Rye, Saline 0.9% - Rhinitis, Allergic, Seasonal, Rhinitis; Allergic, With Asthma | Phase 1 / Phase 2 | Completed | University of Zurich | 60 | 2022-02-10 | 2025-05-21 |
| Airway Immune Response to Allergens (Use Lay Language Here) Segmental allergen challenge - Allergic Asthma, Allergy to Cats | Phase 1 | Unknown | JOSALYN CHO | 12 | 2021-10-28 | 2023-08-31 |
| Andosan in Allergic and Asthma Patients Andosan, Placebo - Allergic Asthma, Allergic Rhinoconjunctivitis | Not applicable | Completed | University Hospital, Akershus | 34 | 2021-08-31 | 2024-06-18 |
| Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma FB825, Placebo - Allergic Asthma | Phase 2 | Recruiting | Oneness Biotech Co., Ltd. | 100 | 2021-07-27 | 2026-01-12 |
Showing 20 of 110. Sign in to see all of them.
Asthma (39) · Hypersensitivity (28) · Rhinitis, Allergic (23) · Dust Mite Allergy (8) · Conjunctivitis, Allergic (5) · Epilepsy, Idiopathic Generalized (4) · Airway Remodeling (3) · Dermatitis, Atopic (3) · Food Hypersensitivity (3) · Lung Diseases (3) · Respiratory Hypersensitivity (3) · Rhinitis (3) · Rhinitis, Allergic, Seasonal (3) · Bronchial Diseases (2) · Bronchial Hyperreactivity (2)
Hypersensitivity, Immediate (65) · Immune System Diseases (65) · Respiratory Tract Diseases (63) · Respiratory Hypersensitivity (61) · Hypersensitivity (39) · Bronchial Diseases (38) · Lung Diseases (38) · Lung Diseases, Obstructive (38) · Nose Diseases (30) · Otorhinolaryngologic Diseases (30) · Rhinitis (27) · Pathological Conditions, Signs and Symptoms (8) · Rhinitis, Allergic (7) · Rhinitis, Allergic, Perennial (7) · Conjunctival Diseases (5)
Omalizumab (21) · Antigens, Dermatophagoides (5) · Allergens (3) · Blood Specimen Collection (3) · Immunotherapy (3) · Desensitization, Immunologic (2) · Fluticasone (2) · Fluticasone-Salmeterol Drug Combination (2) · Salmeterol Xinafoate (2) · Solutions (2) · Vitamin E (2) · levocetirizine (2) · AZD8848 (1) · Albuterol (1) · AndoSan (1)
Novartis Pharmaceuticals (6) · Genentech, Inc. (5) · Johann Wolfgang Goethe University Hospital (5) · Lithuanian University of Health Sciences (5) · Alyatec (3) · University of Wisconsin, Madison (3) · ALK-Abelló A/S (2) · Abionic SA (2) · Aerovance, Inc. (2) · Allergy Therapeutics (2) · AstraZeneca (2) · Creighton University (2) · Inmunotek S.L. (2) · Laboratorios Leti, S.L. (2) · University Medical Center Groningen (2)
United States (26) · Germany (15) · Canada (9) · France (9) · China (8) · Lithuania (5) · Spain (5) · Sweden (5) · United Kingdom (5) · Italy (3) · Netherlands (3) · Switzerland (3) · Austria (2) · Japan (2) · Argentina (1)
Stefan Zielen, Professor (2) · William Busse, MD (2) · Abdelkader Rahmaoui, M.D. (1) · Alessandro Fiocchi (1) · Ana I Tabar, MD PhD (1) · Ana Isabel Tabar Purroy, MD. PhD (1) · Angelika Sager, Dr.med. (1) · Antonio Nieto, MD PhD (1) · Ayca Kiykim (1) · Brian Leaker, MD (1) · Brian O'Connor, MD (1)
PMID 17950857, PMID 18849616, PMID 19001265, PMID 19237390, PMID 19680119, PMID 20001651, PMID 20345983, PMID 20604800, PMID 20920778, PMID 22029856, PMID 22464647, PMID 23987192, PMID 24131304, PMID 24934402, PMID 26296794, PMID 26433533, PMID 26466682, PMID 26843086, PMID 27231527, PMID 27253988, PMID 27297409, PMID 27507228, PMID 28119625, PMID 28254561, PMID 29575037, PMID 30391954, PMID 30919704, PMID 31382020, PMID 31438916, PMID 31856838, PMID 31885750, PMID 32679209, PMID 33099797, PMID 33472687, PMID 33647073, PMID 34187620, PMID 34199925, PMID 34429875, PMID 37794659, PMID 39136011, PMID 40953876
1UG3OD023282 (1), 2009 (1), 5UH3OD023282-05 (1), K23HL080030 (1), R01ES023349 (1), R01ES025124 (1), R01HD100545 (1), R01HL123284 (1)